TIRAT CARMEL, Israel, June 1, 2012 (GLOBE NEWSWIRE) -- D. Medical Industries Ltd. (Nasdaq:DMED - News) (TASE:DMED - News) (“D. Medical” or the “Company”), a medical device company engaged through its subsidiaries in the research, development, manufacture and sale of innovative products for diabetes treatment and drug delivery, today announced financial results for the three months ended March 31, 2012. Results were characterized by the Company’s continuing execution of its low risk and low cost strategy of introducing and promoting the “Spring” brand name to and across various target markets - including the United States, Canada and Europe - initially via the commercial roll out of its Spring Universal(TM) Infusion Sets.
